Delivery Order SPE2DB22D3301-SPE2DB24FY4QL
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $43K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,855.36 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 2, 2025. AmerisourceBergen will perform this delivery order from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,230.90 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,040.41 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of December 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and runs through...
- The Defense Logistics Agency awarded a $27,241.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Gemtesa 75 mg tablets, with performance in Conshohocken, Pennsylvania and completion by August 8, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $13,178.07 to AmerisourceBergen Drug Corp for 90-tablet supplies of Gemtesa 75 mg tablets. This contract, awarded on June 17, 2025, with completion scheduled for June 18, 2025, was competitively procured without set-aside restrictions under a firm fixed-price arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for supply of Gemtesa 75 mg tablets (90-count packages) valued at $17,378.99. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of January 22, 2026. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,245.60 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) with a completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract awarded competitively on January 30, 2026, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $7,983.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of July 24, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the pharmaceutical products will be delivered. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) valued at $53.4K. This competitively awarded, firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,442.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count packages) on January 21, 2026, with an ultimate completion date of January 22, 2026. This non-competitive delivery order utilizes firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under Cencora, Inc. (AmerisourceBergen's parent company), which holds a...